Abstract
OBJECTIVES: To determine the resectability rate for hilar cholangiocarcinoma, to analyze reasons for unresectability, and to devise a presurgical clinical T-staging system. METHODS: Ninety patients with hilar cholangiocarcinomas seen between March 1, 1991, and April 1, 1997, were evaluated. Accurate patterns of disease progression and therapy were evaluable. Disease was staged in 87 patients using extent of ductal tumor involvement, portal vein compromise, and liver atrophy. RESULTS: In 21 patients, disease was deemed unresectable for cure at presentation. In 39 patients, disease was found to be unresectable at laparotomy, 23 secondary to nodal (N2) or distant metastases. Unresectability was the result of metastases in 52% and of locally advanced disease in 28%. Thirty patients (33%) had resection of all gross disease, and 25 of these (83%) had negative histologic margins. Twenty-two patients underwent partial hepatectomy. The 30-day mortality rate was 7%. Projected survival is greater than 60 months in those with a negative histologic margin, with a median follow-up of 26 months. A presurgical T-staging system allows presurgical selection for therapy, predicts partial hepatectomy, and offers an index of prognosis. CONCLUSIONS: In half the patients, unresectability is mainly the result of intraabdominal metastases. Presurgical imaging predicts unresectability based on local extension but is poor for assessing nodal metastases. In one third of patients, disease can be resected for cure with a long median survival. Curative resection depends on negative margins, and hepatic resection is necessary to achieve this. The T-staging system correlates with resectability, the need for hepatectomy, and overall survival.
Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alexander F., Rossi R. L., O'Bryan M., Khettry U., Braasch J. W., Watkins E., Jr Biliary carcinoma. A review of 109 cases. Am J Surg. 1984 Apr;147(4):503–509. doi: 10.1016/0002-9610(84)90013-8. [DOI] [PubMed] [Google Scholar]
- Baer H. U., Stain S. C., Dennison A. R., Eggers B., Blumgart L. H. Improvements in survival by aggressive resections of hilar cholangiocarcinoma. Ann Surg. 1993 Jan;217(1):20–27. doi: 10.1097/00000658-199301000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bismuth H., Corlette M. B. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975 Feb;140(2):170–178. [PubMed] [Google Scholar]
- Callery M. P., Strasberg S. M., Doherty G. M., Soper N. J., Norton J. A. Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy. J Am Coll Surg. 1997 Jul;185(1):33–39. [PubMed] [Google Scholar]
- Cameron J. L., Pitt H. A., Zinner M. J., Kaufman S. L., Coleman J. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg. 1990 Jan;159(1):91–98. doi: 10.1016/s0002-9610(05)80612-9. [DOI] [PubMed] [Google Scholar]
- Hadjis N. S., Blenkharn J. I., Alexander N., Benjamin I. S., Blumgart L. H. Outcome of radical surgery in hilar cholangiocarcinoma. Surgery. 1990 Jun;107(6):597–604. [PubMed] [Google Scholar]
- Hann L. E., Greatrex K. V., Bach A. M., Fong Y., Blumgart L. H. Cholangiocarcinoma at the hepatic hilus: sonographic findings. AJR Am J Roentgenol. 1997 Apr;168(4):985–989. doi: 10.2214/ajr.168.4.9124155. [DOI] [PubMed] [Google Scholar]
- Hann L. E., Schwartz L. H., Panicek D. M., Bach A. M., Fong Y., Blumgart L. H. Tumor involvement in hepatic veins: comparison of MR imaging and US for preoperative assessment. Radiology. 1998 Mar;206(3):651–656. doi: 10.1148/radiology.206.3.9494482. [DOI] [PubMed] [Google Scholar]
- KUWAYTI K., BAGGENSTOSS A. H., STAUFFER M. H., PRIESTLEY J. T. Carcinoma of the major intrahepatic and the extrahepatic bile ducts exclusive of the papilla of Vater. Surg Gynecol Obstet. 1957 Mar;104(3):357–366. [PubMed] [Google Scholar]
- Klempnauer J., Ridder G. J., von Wasielewski R., Werner M., Weimann A., Pichlmayr R. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol. 1997 Mar;15(3):947–954. doi: 10.1200/JCO.1997.15.3.947. [DOI] [PubMed] [Google Scholar]
- Lai E. C., Tompkins R. K., Mann L. L., Roslyn J. J. Proximal bile duct cancer. Quality of survival. Ann Surg. 1987 Feb;205(2):111–118. doi: 10.1097/00000658-198702000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ouchi K., Matsuno S., Sato T. Long-term survival in carcinoma of the biliary tract. Analysis of prognostic factors in 146 resections. Arch Surg. 1989 Feb;124(2):248–252. doi: 10.1001/archsurg.1989.01410020122021. [DOI] [PubMed] [Google Scholar]
- Parker S. L., Tong T., Bolden S., Wingo P. A. Cancer statistics, 1996. CA Cancer J Clin. 1996 Jan-Feb;46(1):5–27. doi: 10.3322/canjclin.46.1.5. [DOI] [PubMed] [Google Scholar]
- Pichlmayr R., Weimann A., Klempnauer J., Oldhafer K. J., Maschek H., Tusch G., Ringe B. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg. 1996 Nov;224(5):628–638. doi: 10.1097/00000658-199611000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schoenthaler R., Phillips T. L., Castro J., Efird J. T., Better A., Way L. W. Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience. Ann Surg. 1994 Mar;219(3):267–274. doi: 10.1097/00000658-199403000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tsuzuki T., Ogata Y., Iida S., Nakanishi I., Takenaka Y., Yoshii H. Carcinoma of the bifurcation of the hepatic ducts. Arch Surg. 1983 Oct;118(10):1147–1151. doi: 10.1001/archsurg.1983.01390100021006. [DOI] [PubMed] [Google Scholar]